The term “functional antibody” refers to those antibodies which can either mimic or interrupt the natural biologic effects associated with ligand-receptor interactions. eBioscience offers an expansive list of Functional Grade Antibodies which may be used for activation, neutralization, and/or blocking studies. These reagents are provided in appropriate buffers containing extremely low endotoxin and are sodium azide free for use in vivo or in vitro applications.
|
Functional Grade Antibodies for Human Proteins
|
| Specificity |
Clone Name |
Cat. No. |
Published Reference |
| B7-H4 (B7-S1, B7x)
|
H74
|
16-5949
|
|
| CCL2 (MCP-1, MCP1, MCAF)
|
2H5
|
16-7096
|
|
| CCL2 (MCP-1, MCP1, MCAF)
|
5D3-F7
|
16-7099
|
|
| CD105 (Endoglin)
|
SN6
|
16-1057
|
|
| CD112 (Nectin-2, PRR2, poliovirus receptor 2)
|
R2.525
|
16-1129
|
|
| CD11a
|
HI111
|
16-0119
|
|
| CD11b (Integrin alpha M, Mac-1) - activation epitope
|
CBRM1/5
|
16-0113
|
|
| CD124 ( IL-4 Receptor alpha, IL-4Ra)
|
X2/45-12
|
16-1249
|
|
| FceRI alpha (high affinity IgE receptor)
|
AER-37
|
16-5899
|
|
| CD127 ( IL-7 Receptor alpha, IL-7Ra, IL7Ra)
|
RDR5
|
16-1278
|
|
| CD13
|
WM-15
|
16-0138
|
|
| CD130 (gp130)
|
AN-HH1
|
16-1307
|
|
| CD14
|
61-D3
|
16-0149
|
Nature. 1998 Apr 2;392(6675):505-9.
|
| CD150 (SLAM, IPO-3, IPO3)
|
A12
|
16-1509
|
|
| CD151 (PETA-3)
|
50-6
|
16-1519}
|
|
| CD152 (CTLA-4, CTLA4)
|
14D3
|
16-1529
|
|
| CD154 (CD40 Ligand, CD40L)
|
24-31
|
16-1548
|
Blood. 2006 Feb 15;107(4):1497-504
|
| CD16
|
CB16
|
16-0168
|
|
| CD180 (RP105, Toll-like Receptor/ TLR Family)
|
MHR73-11
|
16-1809
|
|
| CD184 (CXCR4, Fusin)
|
12G5
|
16-9999
|
J Mol Biol. 2007 Apr 27;368(2):375-87.
|
| CD19
|
HIB19
|
16-0199
|
|
| CD2 (LFA-2)
|
RPA-2.10
|
16-0029
|
|
| CD221 (IGF-1R, Insulin-like Growth Factor-1 Receptor)
|
1H7
|
16-8849
|
|
| CD221 (Insulin-like Growth Factor-1 Receptor, IGF-1R)
|
1H7
|
16-8849
|
|
| CD244 (2B4, p38)
|
C1.7
|
16-5838
|
|
| CD253 (TRAIL)
|
RIK-2
|
16-9927
|
Cancer Immunol Immunother. 2008 Jun;57(6):789-97.
|
| CD262 (DR5, TRAIL-R2)
|
2A7
|
16-9907
|
|
| CD266 (Fn14/TWEAK Receptor)
|
ITEM-2
|
16-9016
|
|
| CD267 (TACI)
|
11H3
|
16-9217
|
|
| CD268 (BR3, BLyS receptor 3, BAFF-R)
|
SA7
|
16-9917
|
|
| CD27
|
LG.7F9
|
16-0271
|
|
| CD27
|
LG.3A10
|
16-0272
|
Int Immunol. 1995 Apr;7(4):551-7.
|
| CD272 (BTLA, B and T lymphocyte attenuator)
|
MIH26
|
16-5979
|
|
| CD273 (B7-DC, PDL-2)
|
MIH18
|
16-5888
|
|
| CD274 (B7-H1, PDL-1)
|
MIH1
|
16-5983
|
|
| CD275 (B7RP-1, ICOS-L)
|
MIH12
|
16-5889
|
|
| CD276 (B7-H3, B7H3)
|
MIH35
|
16-5937
|
|
| CD276 (B7RP-2, B7H3)
|
M3.2D7
|
16-5973
|
|
| CD278 (ICOS)
|
ISA-3
|
16-9948
|
|
| CD279 (PD-1)
|
J116
|
16-9989
|
|
| CD28
|
CD28.6
|
16-0288
|
|
| CD28 (costimulatory)
|
CD28.2
|
16-0289
|
J Immunol. 2006 Mar 1;176(5):2765-72.
|
| CD281 (Toll-like receptor 1, TLR-1)
|
GD2.F4
|
16-9911
|
|
| CD282 (Toll-like receptor 2, TLR-2)
|
T2.5
|
16-9024
|
|
| CD282 (Toll-like receptor 2, TLR-2)
|
TL2.1
|
16-9922
|
|
| CD283 (Toll-like receptor 3, TLR-3)
|
TLR3.7
|
16-9039
|
|
| CD284 (Toll-like receptor 4, TLR-4)
|
HTA125
|
16-9917
|
|
| CD3
|
SK7
|
16-0036
|
|
| CD3
|
OKT3
|
16-0037
|
Int Immunol. 2008 Sep;20(9):1147-54.
|
| CD3
|
UCHT1
|
16-0038
|
J Immunol. 1984 Jul;133(1):129-32.
|
| CD3
|
HIT3a
|
16-0039
|
Diabetes. 2005 May;54(5):1407-14.
|
| CD300e (IREM-2, CLM-2)
|
UP-H2
|
16-3007
|
|
| CD31 (PECAM-1)
|
WM-59
|
16-0319
|
|
| CD317 (BST2, Tetherin)
|
26F8
|
16-3179
|
|
| CD32
|
6C4
|
16-0329
|
|
| CD338 (ABCG2, Bcrp1, MXR)
|
5D3
|
16-8888
|
|
| CD4
|
OKT4
|
16-0048
|
|
| CD4
|
RPA-T4
|
16-0049
|
J Leukoc Biol. 2007 Dec;82(6):1455-65.
|
| CD40
|
5C3
|
16-0409
|
Int Immunol. 1999 Jan;11(1):11-20
|
| CD42b
|
HIP1
|
16-0429
|
|
| CD44 (Pgp-1, Ly-24)
|
IM7
|
16-0441
|
Scand J Immunol. 1997 Feb;45(2):213-20.
|
| CD45R (B220)
|
RA3-6B2
|
16-0452
|
|
| CD47
|
B6H12
|
16-0479
|
|
| CD48 (SLAM family)
|
156-4H9
|
16-0489
|
|
| CD49b (Integrin alpha 2)
|
Y418
|
16-0498
|
|
| CD49d (Integrin alpha 4)
|
9F10
|
16-0499
|
J Immunol Methods. 2007 Aug 31;325(1-2):20-34.
|
| CD51/61
|
23C6
|
16-0519
|
Int J Cancer. 1998 Jul 3;77(1):82-93.
|
| CD54 (ICAM-1)
|
HA58
|
16-0549
|
Eur J Immunol. 2003 Aug;33(8):2098-107.
|
| CD56 (N-CAM, NCAM)
|
MEM188
|
16-0569
|
|
| CD57
|
TB01
|
16-0577
|
|
| CD62L (L-selectin)
|
DREG56
|
16-0629
|
|
| CD62P (P-selectin)
|
AK-4
|
16-0628
|
|
| CD64
|
|
16-0649
|
|
| CD71 (transferrin receptor)
|
OKT9
|
16-0719
|
|
| CD8
|
OKT8
|
16-0086
|
|
| CD8 (CD8a; alpha chain)
|
HIT8a
|
16-0089
|
|
| CD80 (B7-1, B71)
|
2D10.4
|
16-0809
|
|
| CD85d (ILT4)
|
42D1
|
16-5149
|
|
| CD85g (ILT7, IL-T7)
|
17G10.2
|
16-5179
|
|
| CD85k (ILT3, GM 4d)
|
ZM4.1
|
16-5139
|
|
| CD86 (B7-2, B72)
|
IT2.2
|
16-0869
|
|
| CD95 (Fas/APO-1)
|
EOS9.1
|
16-0958
|
|
| CD95 Ligand (Fas Ligand, CD178)
|
NOK-1
|
16-9919
|
Cancer Res. 2005 Apr 15;65(8):3017-24.
|
| gd-TCR
|
B1.1
|
16-9959
|
|
| GM-CSF (Granulocyte/Macrophage-Colony Stimulating Factor)
|
BVD2-23B6
|
16-7336
|
|
| HLA-ABC
|
W6/32
|
16-9983
|
|
| Human FcgR-Binding Inhibitor
|
|
16-9161
|
|
| IFN-a1 (Interferon-alpha 1)
|
HTLa
|
16-7388
|
|
| IFN-b (Interferon-beta)
|
A1
|
16-9978
|
|
| IFN-g (Interferon-gamma, IFN-g)
|
MD-1
|
16-7317
|
|
| IFN-g (Interferon-gamma, IFN-g)
|
NIB-42
|
16-7318
|
|
| IL-10 (Interleukin-10, IL10)
|
JES3-9D7
|
16-7108
|
|
| IL-12 (Interleukin-12, IL12) / IL-23 (Interleukin-23, IL23) p40/70
|
C8.6
|
16-7129
|
|
| IL-13 (Interleukin-13, IL13)
|
PVM13-1
|
16-7139
|
|
| IL-17A (Interleukin-17A, IL17A)
|
eBio64CAP17
|
16-7178
|
|
| IL-1a (Interleukin-1 alpha, IL1a)
|
CRM8
|
16-7019
|
|
| IL-1b (Interleukin-1 beta, IL1b)
|
CRM56
|
16-7018
|
|
| IL-4 (Interleukin-4, IL4)
|
MP4-25D2
|
16-7048
|
|
| IL-5 (Interleukin-5, IL5)
|
TRFK5
|
16-7052
|
|
| IL-5 (Interleukin-5, IL5)
|
JES1-5A10
|
16-7059
|
|
| IL-6 (Interleukin-6, IL6)
|
MQ2-13A5
|
16-7069
|
|
| Integrin Beta 5
|
KN52
|
16-0497
|
|
| LAP (latency-associated peptide)
|
VB3A9
|
16-9823
|
|
| MDR1 (CD243, P-gp, P-glycoprotein, ABCB1)
|
UIC2
|
16-2439
|
|
| MICA/MICB (MIC A/B)
|
6D4
|
16-5788
|
|
| NKG2D / CD314 (activating)
|
1D11
|
16-5878
|
|
| NKG2D / CD314 (activating)
|
5C6
|
16-5879
|
J Immunol. 2008 Jun 1;180(11):7249-58.
|
| Podoplanin
|
NZ-1.3
|
16-9381
|
|
| TNF-a (Tumor Necrosis Factor alpha)
|
MAb1
|
16-7348
|
|
| TWEAK
|
CARL-1
|
16-9915
|
|
| V beta 5.1 TCR
|
LC-4
|
16-5832
|
Eur J Immunol. 1989 Oct;19(10):1911-9.
|
|
Functional Grade Antibodies for Mouse Proteins
|
| Specificity |
Clone Name |
Cat. No. |
Published References |
| alpha-GalCer:CD1d
|
L363
|
16-2019
|
J Immunol Methods. 2007 May 31;323(1):11-23
|
| B7-H4
|
|
16-5972
|
Kidney Int. 2006 Dec;70(12):2092-9.
|
| B7RP-1
|
HK5.3
|
16-5985
|
|
| CCL2 (MCP-1)
|
2H5
|
16-7096
|
|
| CD100 (SEMA4D)
|
BMA12
|
16-1001
|
|
| CD103
|
2E7
|
16-1031
|
Eur. J. Immunol. 1997.27: 1756-1761
|
| CD106 (VCAM-1)
|
429
|
16-1061
|
Transpl Immunol. 2006 Nov;16(3-4):185-93.
|
| CD115 (CSF-1R, CSF-1 receptor)
|
AFS98
|
16-1152
|
Blood. 1997 Nov 1;90(9):3516-23.
|
| CD335 (NKp46)
|
29A1.4
|
16-3351
|
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3384-9.
|
| CD117 (c-Kit)
|
ACK2
|
16-1172
|
Science. 23;318(5854):1296-9.
|
| CD11a
|
M17/4
|
16-0111
|
J Biol Chem. 2009 May 8;284(19):12645-53
|
| CD11b (Mac-1 alpha)
|
M1/70
|
16-0112
|
J Appl Physiol. 2003 Sep;95(3):969-76
|
| CD11c
|
N418
|
16-0114
|
|
| CD120a (TNFR1 p55)
|
55R-170
|
16-1202
|
|
| CD122 (IL-2Rb)
|
5H4
|
16-1221
|
|
| CD122 (IL-2Rb, IL2Rb)
|
TM-b1
|
16-1222
|
|
| CD126 IL-6Ra, IL6Ra)
|
D7715A7
|
16-1261
|
J Immunol. 2007 Feb 1;178(3):1767-73
|
| CD127 (IL-7Ra, IL7Ra)
|
A7R34
|
16-1271
|
|
| CD133 (Prominin I)
|
13A4
|
16-1331
|
|
| CD134 (OX40, OX-40)
|
OX-86
|
16-1341
|
|
| CD135 (Flk-2, Flk2, Flt3, Flt-3, Ly-72)
|
A2F10
|
16-1351
|
|
| CD137
|
17B5
|
16-1371
|
|
| CD137 Ligand (4-1BB)
|
TKS-1
|
16-5901
|
|
| CD14
|
Sa2-8
|
16-0141
|
|
| CD140a (PDGFRa)
|
APA5
|
16-1401
|
|
| CD140b (PDGFRb)
|
APB5
|
16-1402
|
J Am Coll Cardiol. 2006 Dec 5;48(11):2315-23.
|
| CD144 (VE-Cadherin)
|
BV13
|
16-1441
|
|
| CD147 (Basigin, EMMPRIN)
|
RL73
|
16-1471
|
|
| CD150 (SLAM, IPO-3)
|
9D1
|
16-1501
|
Blood. 100(8): 2899-907.
|
| CD152 (CTLA-4, CTLA4)
|
9H10
|
16-1521
|
|
| CD153 (CD30 Ligand, CD30L)
|
RM153
|
16-1531
|
|
| CD154 (CD40 Ligand, CD40L, gp39)
|
MR1
|
16-1541
|
J Immunol. 1997 Jan 1;158(1):359-66.
|
| CD16/32 - blocks Fc binding
|
|
16-0161
|
J Leukoc Biol. 2006 Jan;79(1):40-5.
|
| CD160 (BY55)
|
CNX46-3
|
16-1601
|
|
| CD18 (Integrin beta 2)
|
M18/2
|
16-0181
|
|
| CD180 (RP105, TLR Family)
|
RP/14
|
16-1801
|
|
| CD183 (CXCR3)
|
CXCR3-173
|
16-1831
|
Transplantation. 2008 Jul 15;86(1):137-147
|
| CD184 (CXCR4, FUSIN)
|
2B11
|
16-9991
|
J Immunol. 1998 Feb 1;160(3):1522-31.
|
| CD19
|
MB19-1
|
16-0191
|
J Biol Chem. 2001 Nov 30;276(48):44820-7.
|
| CD19
|
1D3
|
16-0193
|
Eur J Immunol. 1996 Jan;26(1):238-42.
|
| CD197 (CCR7)
|
4B12
|
16-1971
|
|
| CD1d
|
1B1
|
16-0011
|
J Immunol. 2005 Sep 1;175(5):3102-9.
|
| CD2 (LFA-2)
|
RM2-5
|
16-0021
|
|
| CD201 (EPCR)
|
|
16-2012
|
Blood. 2006 Mar 15;107(6):2317-21.
|
| CD201 (EPCR, endothelial protein C receptor)
|
mRCR-16
|
16-2011
|
|
| CD202 (Tie-2, Tek)
|
TEK4
|
16-5987
|
|
| CD209b (SIGN-R1, (C-type lectin)
|
22D1
|
16-2093
|
|
| CD21/CD35 (CR2/CR1)
|
8D9
|
16-0211
|
|
| CD21/CD35 (CR2/CR1)
|
4E3
|
16-0212
|
|
| CD223 (LAG3, LAG-3)
|
C9B7W
|
16-2231
|
|
| CD226
|
10E5
|
16-2261
|
J Immunol. 2005 Aug 1;175(3):1558-65
|
| CD24 (Heat Stable Antigen)
|
M1/69
|
16-0242
|
|
| CD25 ( IL-2Ra, p55)
|
PC61.5
|
16-0251
|
|
| CD252 (OX40 Ligand, CD134L)
|
RM134L
|
16-5905
|
|
| CD253 (TRAIL)
|
N2B2
|
16-5951
|
|
| CD262 (DR5, TRAIL-R2)
|
MD5-1
|
16-5883
|
|
| CD266 (TWEAK Receptor)
|
ITEM-2
|
16-9061
|
|
| CD27
|
LG.7F9
|
16-0271
|
|
| CD27
|
LG.3A10
|
16-0272
|
Int Immunol. 1995 Apr;7(4):551-7.
|
| CD272 (BTLA)
|
6F7
|
16-5950
|
Am J Transplant. 2007 Dec;7(12):2663-74.
|
| CD273 (B7DC, PDL-2)
|
TY25
|
16-5986
|
|
| CD274 (B7-H1, PDL-1)
|
MIH5
|
16-5982
|
|
| CD276 (B7-H3, B7H3)
|
MIH35
|
16-5937
|
|
| CD276 (B7RP-2, B7H3)
|
M3.2D7
|
16-5973
|
|
| CD278 (ICOS)
|
7E.17G9
|
16-9942
|
J Exp Med. 2004 Jun 7;199(11):1479-89.
|
| CD278 (ICOS)
|
C398.4A
|
16-9949
|
|
| CD279 (PD-1)
|
RMP1-30
|
16-9981
|
|
| CD279 (PD-1)
|
RMP1-14
|
16-9982
|
J Exp Med. 2006 Nov 27;203(12):2737-47.
|
| CD279 (PD-1)
|
J43
|
16-9985
|
J Exp Med. 2003 Jul 7;198(1):63-9.
|
| CD28
|
|
16-0281
|
J Immunol. 2008 Aug 15;181(4):2522-32.
|
| CD282 (Toll-like receptor 2, TLR2)
|
6C2
|
16-9021
|
|
| CD282 (Toll-like receptor 2, TLR2)
|
T2.5
|
16-9024
|
|
| CD29 (Integrin b1 Chain)
|
HMb1-1
|
16-0291
|
|
| CD3
|
145-2C11
|
16-0031
|
J Immunol. 2005 Nov 15;175(10):6420-7.
|
| CD3
|
17A2
|
16-0032
|
Infect Immun. 1998 May;66(5):1962-7
|
| CD3
|
500A2
|
16-0033
|
|
| CD30
|
mCD30.1
|
16-0301
|
J Immunol. 1996 Jan 15;156(2):442-9.
|
| CD305 (LAIR-1)
|
113
|
16-3051
|
|
| CD31 (PECAM-1)
|
|
16-0311
|
|
| CD314 (NKG2D)
|
A10
|
16-5872
|
|
| CD314 (NKG2D)
|
C7
|
16-5873
|
|
| CD314 (NKG2D)
|
MI6
|
16-5880
|
Immunity. 2004 Jun;20(6):799
|
| CD314 (NKG2D)
|
CX5
|
16-5882
|
INFECTION AND IMMUNITY, May 2006, p. 2578–2586
|
| CD34
|
RAM34
|
16-0341
|
|
| CD38
|
|
16-0381
|
J Immunol 158(3): 1108-15
|
| CD39
|
24DMS1
|
16-0391
|
|
| CD4 (L3T4)
|
GK1.5
|
16-0041
|
|
| CD4 (L3T4)
|
RM4-5
|
16-0042
|
|
| CD4 (L3T4)
|
RM4-4
|
16-0043
|
|
| CD40
|
1C10
|
16-0401
|
Infect Immun. 2005 May;73(5):3115-23.
|
| CD40
|
HM40-3
|
16-0402
|
Int Immunol. 2000 Apr;12(4):517-26.
|
| CD41 (Fibrinogen Receptor, Iintegrin alpha Iib)
|
eBioMWReg30
|
16-0411
|
Blood. 1999 Jul 15;94(2):684-93
|
| CD43 (Leukosialin)
|
eBioR2/60
|
16-0431
|
|
| CD44 (Pgp-1, Ly-24)
|
IM7
|
16-0441
|
Scand J Immunol. 1997 Feb;45(2):213-20.
|
| CD45
|
30-F11
|
16-0451
|
Blood. 2003 Mar 15;101(6):2434-9.
|
| CD45R (B220)
|
RA3-6B2
|
16-0452
|
J Leukoc Biol. 2005 Nov;78(5):1106-17.
|
| CD47
|
miap301
|
16-0471
|
J Immunol. 2000 Apr 1;164(7):3652-8.
|
| CD48 (BCM1)
|
HM48-1
|
16-0481
|
|
| CD49b (Integrin alpha 2)
|
HMa2
|
16-0491
|
|
| CD49d
|
R1-2
|
16-0492
|
Am J Pathol. 2003 May;162(5):1591-601.
|
| CD51 (Integrin alpha v)
|
RMV-7
|
16-0512
|
J Exp Med. 2001 Nov 5;194(9):1219-29.
|
| CD54 (ICAM-1)
|
YN1/1.7.4
|
16-0541
|
|
| CD54 (ICAM-1)
|
KAT1
|
16-0542
|
|
| CD61
|
2C9.G3
|
16-0611
|
|
| CD62L (L-selectin, LECAM-1, Ly-22)
|
MEL-14
|
16-0621
|
Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4)
|
| CD62P (P-selectin)
|
PseI.KO2.12
|
16-0622
|
|
| CD69 (Very Early Activation Antigen)
|
H1.2F3
|
16-0691
|
J Immunol. 2002 Jan 1;168(1):87-94.
|
| CD70
|
FR70
|
16-0701
|
J Immunol. 2004 Feb 1;172(3):1691-8.
|
| CD71 (Transferrin Receptor)
|
R17217
|
16-0711
|
|
| CD73 (Ecto-5'-nucleotidase)
|
TY/11.8
|
16-0731
|
|
| CD8 (alpha subunit, CD8a, Ly-2)
|
53-6.7
|
16-0081
|
Circulation. 2006 Nov 7;114(19):2056-64
|
| CD80
|
16-10A1
|
16-0801
|
J Am Soc Nephrol. 2005 Jul;16(7):2012-22
|
| CD81 (TAPA-1)
|
EAT2
|
16-0811
|
|
| CD83
|
Michel-17
|
16-0831
|
|
| CD86 (B7-2, B72)
|
PO3.1
|
16-0861
|
|
| CD86 (B7-2, B72)
|
GL1
|
16-0862
|
|
| CD90 (Thy-1, Thy1)
|
G7
|
16-0901
|
|
| CD90.2
|
30-H12
|
16-0903
|
|
| CD95 Ligand (Fas Ligand, CD178, FasL)
|
MFL3
|
16-5911
|
|
| CD95 Ligand (Fas Ligand, CD178, FasL)
|
MFL4
|
16-5912
|
|
| DII1 (Delta-like 1)
|
HMD1-5
|
16-5767
|
|
| F4/80 Antigen
|
BM8
|
16-4801
|
|
| FceRI alpha
|
MAR1
|
16-5898
|
|
| FR4 (Folate Receptor-4)
|
TH6
|
16-5446
|
|
| gd-TCR
|
UC7-13D5
|
16-5811
|
|
| GITR (TNFRSF18, AITR)
|
DTA-1
|
16-5874
|
J Exp Med. 2005 Oct 3;202(7):885-91
|
| GM-CSF
|
MP1-22E9
|
16-7331
|
|
| IFNAR-1 (IFN-a/b Receptor 1)
|
MAR1-5A3
|
16-5945
|
|
| IFN-g
|
XMG1.2
|
16-7311
|
|
| IFN-g
|
R4-6A2
|
16-7312
|
|
| IFN-g
|
AN-18
|
16-7313
|
|
| IL-10 (Interleukin-10)
|
JES5-16E3
|
16-7101
|
|
| IL-10 (Interleukin-10)
|
JES5-2A5
|
16-7102
|
|
| IL-12/ IL-23 p40
|
C17.8
|
16-7123
|
|
| IL-13 (Interleukin-13)
|
eBio13A
|
16-7133
|
|
| IL-13 (Interleukin-13)
|
eBio1316H
|
16-7135
|
|
| IL-15 (Interleukin-15)
|
AIO.3
|
16-7154
|
|
| IL-15/IL-15R
|
GRW15PLZ
|
16-8156
|
|
| IL-17A (Interleukin-17A)
|
eBioMM17F3
|
16-7173
|
|
| IL-17A (Interleukin-17A)
|
17CK15A5
|
16-7175
|
|
| IL-1a (Interleukin-1 alpha, IL1a)
|
ALF-161
|
16-7011
|
|
| IL-1b (Interleukin-1 beta, IL1b)
|
B122
|
16-7012
|
|
| IL-2 (Interleukin-2)
|
JES6-5H4
|
16-7021
|
|
| IL-2 (Interleukin-2)
|
JES6-1A12
|
16-7022
|
|
| IL-22 (Interleukin-22)
|
IL22JOP
|
16-7222
|
|
| IL-23 (Interleukin-23) p19
|
G23-8
|
16-7232
|
|
| IL-4 (Interleukin-4)
|
11B11
|
16-7041
|
|
| IL-5 (Interleukin-5)
|
TRFK5
|
16-7052
|
|
| IL-6 (Interleukin-6)
|
MP5-20F3
|
16-7061
|
|
| Integrin Beta 5
|
KN52
|
16-0497
|
|
| Jagged-1
|
HMJ1-29
|
16-3391
|
|
| KLRG1/MAFA
|
2F1
|
16-5893
|
|
| LPAM-1
|
DATK32
|
16-5887
|
|
| Ly108
|
13G3-19D
|
16-1508
|
|
| Ly-49I
|
YLI-90
|
16-5895
|
|
| Ly-6A/E (Sca-1)
|
D7
|
16-5981
|
|
| Ly-6G (Gr-1)
|
RB6-8C5
|
16-5931
|
|
| Lymphotoxin-beta Receptor (LTbR)
|
3C8
|
16-5671
|
|
| MAdCAM-1
|
MECA-367
|
16-5997
|
|
| MD-1 (TLR Family)
|
MD113
|
16-9931
|
|
| MHC Class I
|
28-14-8
|
16-5999
|
|
| MHC Class II
|
NIMR-4
|
16-5322
|
|
| MHC Class II (I-A/I-E)
|
M5/114.15.2
|
16-5321
|
|
| NK-1.1 (NK1.1, NKR-P1C, Ly-55)
|
PK136
|
16-5941
|
|
| NKG2A/C/E
|
20d5
|
16-5896
|
|
| PDCA-1
|
|
16-3172
|
J Immunol. 177:3260-3265
|
| RAE-1g
|
CX1
|
16-5881
|
|
| Siglec H
|
eBio440c
|
16-0333
|
|
| TCR beta (TCRb)
|
H57-597
|
16-5961
|
J Exp Med. 1993 Sep 1;178(3):971-84.
|
| TER-119 (Ly-76)
|
TER-119
|
16-5921
|
|
| TIM-3
|
8B.2C12
|
16-5871
|
J Immunol. 2006 Jun 1;176(11):6411-6415
|
| TNFa (TNF-alpha)
|
MP6-XT22
|
16-7321
|
|
| TNFa (TNF-alpha)
|
MP6-XT3
|
16-7322
|
|
| TNFa (TNF-alpha)
|
1F3F3D4
|
16-7325
|
|
| TNFa (TNF-alpha)
|
TN3-19
|
16-7423
|
|
| Toll-like receptor 4/MD-2
|
MTS510
|
16-9924
|
|
| Toll-like receptor 4/MD-2
|
UT12
|
16-9925
|
|
| Toll-like receptor 4/MD-2
|
UT18
|
16-9926
|
|
| TSLP (thymic stromal derived lymphopoietin)
|
eBio28F12}
|
16-5491
|
|
| TWEAK
|
MTW-1
|
16-9913
|
|
| VEGFR3
|
AFL4
|
16-5988
|
Blood. 2000 Jul 15;96(2):546-53.
|
|
Functional Grade Antibodies for Rat Proteins
|
| Specificity |
Clone Name |
Cat. No. |
Published References |
| CCL2 (MCP-1, MCP1, MCAF)
|
2H5
|
16-7096
|
|
| CD278 (ICOS)
|
C398.4A
|
16-9949
|
|
| alpha beta TCR (abTCR, TCRab)
|
R73
|
16-5960
|
|
| TNFa (TNF-alpha, TNF-a)
|
TN3-19
|
16-7423
|
|
| CD3
|
G4.18
|
16-0030
|
|
| CD8a
|
OX8
|
16-0084
|
|
| CD8b (beta subunit; CD8b, Ly-3)
|
|
16-0080
|
|
| CD27
|
LG.7F9
|
16-0271
|
|
| CD28
|
JJ319
|
16-0280
|
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10382-7
|
| CD80 (B7-1, B71)
|
3H5
|
16-0800
|
|
| CD86 (B7-2, B72)
|
24F
|
16-0860
|
|
| CD95 Ligand (Fas Ligand, CD178, FasL)
|
MFL4
|
16-5912
|
|
| CD106 (VCAM-1)
|
MR106
|
16-1060
|
|
| CD134L (CD252, OX40 Ligand, OX-40L)
|
ATM2
|
16-1340
|
|
|
